HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas D Hartkopf Selected Research

giredestrant

2/2022Update Breast Cancer 2021 Part 4 - Prevention and Early Stages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas D Hartkopf Research Topics

Disease

53Breast Neoplasms (Breast Cancer)
03/2022 - 03/2011
26Neoplasms (Cancer)
01/2022 - 02/2011
6Triple Negative Breast Neoplasms
05/2021 - 10/2019
5Neoplasm Metastasis (Metastasis)
01/2021 - 12/2012
4Disease Progression
06/2021 - 04/2020
4Circulating Neoplastic Cells
07/2020 - 03/2011
3Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 03/2018
2Vomiting
01/2021 - 03/2018
2Nausea
01/2021 - 03/2018
2Ovarian Epithelial Carcinoma
01/2020 - 01/2018
2Residual Neoplasm
01/2020 - 01/2018
1Pathologic Complete Response
05/2021
1Fatigue
01/2021
1Abdominal Pain (Pain, Abdominal)
01/2021
1Exanthema (Rash)
01/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020
1Arthralgia (Joint Pain)
10/2019
1Pain (Aches)
10/2019
1Musculoskeletal Pain
10/2019
1Brain Neoplasms (Brain Tumor)
12/2018
1Carcinoma (Carcinomatosis)
10/2018
1Alopecia (Baldness)
03/2018
1Leiomyoma (Uterine Fibroids)
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
11/2017
1Ischemia
09/2012
1Infections
11/2010
1Glioma (Gliomas)
11/2010

Drug/Important Bio-Agent (IBA)

12Hormones (Hormone)IBA
05/2021 - 02/2018
8Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2018
5pertuzumabIBA
06/2021 - 01/2019
4Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2022 - 03/2018
4Immune Checkpoint InhibitorsIBA
05/2021 - 12/2016
3Phenobarbital (Luminal)FDA Link
01/2022 - 01/2020
3LigandsIBA
09/2021 - 12/2016
3human ERBB2 proteinIBA
01/2021 - 12/2018
3Progesterone Receptors (Progesterone Receptor)IBA
08/2020 - 11/2014
3Estrogen ReceptorsIBA
08/2020 - 11/2014
3Biological ProductsIBA
10/2019 - 12/2012
3TabletsIBA
01/2019 - 01/2017
2neratinibIBA
06/2021 - 01/2021
2Immunoconjugates (Immunoconjugate)IBA
05/2021 - 04/2021
2Pharmaceutical PreparationsIBA
02/2021 - 12/2020
2Trastuzumab (Herceptin)FDA Link
01/2021 - 01/2019
2Ado-Trastuzumab EmtansineIBA
10/2020 - 10/2019
2ProgesteroneFDA LinkGeneric
08/2020 - 12/2016
2Estrogens (Estrogen)FDA Link
08/2020 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2018
1abemaciclibIBA
03/2022
1giredestrantIBA
02/2022
1talazoparibIBA
02/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Immune Checkpoint ProteinsIBA
09/2021
1DisintegrinsIBA
06/2021
1Metalloproteases (Metalloproteinases)IBA
06/2021
1Capecitabine (Xeloda)FDA Link
06/2021
1Cyclin-Dependent Kinase 4IBA
05/2021
1sacituzumab govitecanIBA
04/2021
1AlpelisibIBA
04/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1seribantumabIBA
11/2020
1histidine-rich proteinsIBA
11/2020
1Indicators and Reagents (Reagents)IBA
07/2020
1Histones (Histone)IBA
01/2020
1TransferasesIBA
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1Androgen Receptors (Androgen Receptor)IBA
01/2020
1atezolizumabIBA
12/2019
1Letrozole (Femara)FDA LinkGeneric
10/2019
1Aromatase InhibitorsIBA
10/2019
1Keratins (Keratin)IBA
06/2018
1Toll-Like Receptor 4IBA
01/2018
14-azidobenzylcarazolol (pABC)IBA
01/2018
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
11/2017
1AntibodiesIBA
12/2016
1ParaffinIBA
02/2016
1Pyruvic Acid (Pyruvate)IBA
09/2012
1Succinate Dehydrogenase (Fumarate Reductase)IBA
09/2012
1Therapeutic UsesIBA
11/2010

Therapy/Procedure

42Therapeutics
03/2022 - 03/2011
6Drug Therapy (Chemotherapy)
05/2021 - 03/2011
4Neoadjuvant Therapy
02/2022 - 01/2018
4Oncolytic Virotherapy
01/2022 - 02/2011
3Immunotherapy
09/2021 - 10/2019
2Precision Medicine
11/2018 - 11/2018
1Secondary Prevention
04/2020
1Ligation
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
12/2019
1Segmental Mastectomy (Lumpectomy)
06/2019
1Uterine Myomectomy
01/2018
1Palliative Care (Palliative Therapy)
01/2017
1Adjuvant Chemotherapy
02/2016
1Radiotherapy
11/2010